Chaitanya Divgi
Seminars
Tuesday 1st December 2026
Alpha vs Beta: Determining When, Where & Why Different Therapeutic Isotopes Deliver the Greatest Clinical Advantage
11:30 am
- Evaluating how alpha- and beta-emitting isotopes differ in tissue penetration, potency, bystander effect and suitability across distinct tumour and disease settings
- Understanding why isotope selection should be driven by tumour biology, disease burden, delivery vehicle and therapeutic intent rather than momentum toward a single modality class
- Defining where alpha emitters may offer transformative efficacy versus where beta emitters may provide superior tolerability, scalability or broader clinical applicability
